HCA Healthcare's (HCA) '26 EBITDA Growth Key Investor Debate - Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $525.00 price target on HCA Healthcare Inc (NYSE: HCA).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
